Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Antlia Bioscience Logo
Antlia Bioscience CB Rank
299602
Heat Score
84
Antlia Bioscience develops peptide-based therapies to treat cardiovascular and metabolic diseases.
Founded
obfuscation
Private Encinitas, California, United States antliabio.com/
Biotechnology
Health Care
Medical
Overview

Antlia Bioscience
Heat Score
84

Growth Score
pts
in past quarter
Heat Score 84
2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Antlia Bioscience

CB Rank
299602
Antlia Bioscience develops peptide-based therapies to treat cardiovascular and metabolic diseases.
Founded
obfuscation
Private Encinitas, California, United States antliabio.com/
Biotechnology
Health Care
Medical

Details

Legal Name Antlia Bioscience, Inc
Operating Status Active
Company Type For Profit
Founders  Brian L. Johnson, Nigel Shankley
About the Company
Antlia Bioscience develops peptide-based therapies to treat cardiovascular and metabolic diseases.
Phone Number 619-990-0290
Contact Email bjohnson@antliabio.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Peptide-based Therapeutics for Cardiometabolic Diseases
Therapeutic peptides designed to treat chronic cardiovascular and metabolic conditions by targeting disease mechanisms.

Research & Development

Antlia Bioscience is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Contacts 1
News

News and Press

News•Nov 14, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$230.9KThis year, Antlia Bioscience is projected to spend $230.9K on IT, according to Aberdeen.

Active Website Tech Count

10Antlia Bioscience is actively using 10 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

2The intellectual property of Antlia Bioscience includes 2 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Antlia Bioscience's headquarters? Antlia Bioscience is located in Encinitas, California, United States.Who are Antlia Bioscience's competitors? Alternatives and possible competitors to Antlia Bioscience may include Visum Pharma, Protomer Technologies, and  proteonomix.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|